Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies

By sjmartinez • November 26, 2024

Chin KM, Channick R, Kim NH, Ong R, Turricchia S, Martin N, Mitchell L, McLaughlin VV. Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies. Cardiol Ther. 2024 Nov 25. doi: 10.1007/s40119-024-00386-1. Epub ahead of print. PMID: 39585521.

Tags: congenital heart disease, Macitentan, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world evidence

Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data and Substance Use Among Middle School Students

DiPentino R, Meza BPL, Jackson N, Dosanjh KK, Dudovitz RN, Wong MD. Could School Function Be an Adolescent Health Vital Sign? Associations Between Gradebook Data[...]

Yellow Fever Reemergence in Tolima, Colombia 2024-2025: An Eco-epidemiological Study

Judson SD, Stephan N, Machuca S, Henao-Martínez AF, Parra-Henao G, Vivas R, Alarcón-Robayo JF, Vera Soto MJ, Vargas H. Yellow Fever Reemergence in Tolima, Colombia[...]

Safety and Efficacy of the Ahmed ClearPath versus Ahmed ClearPath Small Tube at Six Months: A Retrospective Comparative Cohort Study

Shi KSY, Dorairaj EA, Bhartiya S, Oyama K, Wang W, Thé RY, Moreno KB, Wang M, Towne C, Qozat IM, Banoub RG, Dorairaj SK. Safety[...]